Atlas Trials

[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma

Clinical trial NCT03648073 · COMPLETED

Trial details

NCT number
NCT03648073
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-01-30
Primary completion
2022-02-03
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.